What was recalled
The U.S. Food and Drug Administration has issued a Class II recall affecting a specific batch of prescription medication distributed by Accord Healthcare, Inc. This action centers on Levothyroxine Sodium Tablets, USP, specifically those with a strength of 25 mcg (0.025 mg). These are not over-the-counter supplements but are strictly Rx Only medications, meaning they require a valid prescription from a healthcare provider to be dispensed. The product is manufactured for Accord Healthcare, Inc., which is headquartered in Raleigh, North Carolina, at the address 27617. However, the physical manufacturing took place overseas by Intas Pharmaceuticals Limited, located in Selaqui, Dehradun, India.
The recall is precise and limited to 1000-count bottles of this particular dosage. It is critical for consumers and pharmacists to identify the exact National Drug Code (NDC) associated with this product, which is 16729-447-17. The scope of the distribution was nationwide within the United States, meaning that patients across all states may potentially possess these bottles depending on their pharmacy’s supply chain at the time of purchase. The recall was officially initiated on August 6, 2026, indicating that this is a recent regulatory action requiring immediate attention from those who have been prescribed this specific thyroid medication.
To determine if you are affected, you must look closely at the lot numbers and expiration dates printed on the bottle. The recall covers several distinct lots with varying expiration windows. Specifically, the following lot numbers are included in this recall effort: D2401927 and D2401833, both of which have an expiration date of August 31, 2026; D2402551 and D2402552, which expire on November 30, 2026; D2500220, expiring December 31, 2026; and finally, D2500223, which has a later expiration date of January 31, 2027. If your bottle matches the NDC 16729-447-17 and contains one of these specific lot numbers, it is part of this recall. Accord Healthcare, Inc. has identified these units as potentially subpotent, which is the primary reason for their removal from the market to ensure patient safety.
The hazard, explained
At the heart of this recall is a subtle but significant issue known as a subpotent drug. In plain terms, this means that the Levothyroxine Sodium Tablets in question do not contain the full amount of active ingredient listed on the label. While the bottle says you are getting exactly 25 mcg (0.025 mg) of levothyroxine sodium per tablet, laboratory testing or quality control data has revealed that the actual concentration is lower than intended. This is not a case of contamination with foreign objects or incorrect labeling of the drug name; rather, it is a failure in the manufacturing precision where the chemical potency falls short of the standard.
Levothyroxine is not like a pain reliever you might take occasionally for a headache. It is a synthetic form of thyroxine, a critical hormone produced by your thyroid gland that regulates your metabolism, heart rate, body temperature, and energy levels. Because the body relies on a very narrow window of hormone levels to function correctly, consistency is everything. When you have hypothyroidism (an underactive thyroid), your doctor prescribes this medication to replace what your body cannot make. The goal is to keep your Thyroid Stimulating Hormone (TSH) levels within a specific range. If the drug is subpotent, it fails to provide the necessary hormonal support.
The physical mechanism of harm here is gradual and systemic. When you take a tablet that has less active ingredient than expected, your blood serum levels of thyroid hormone drop below the therapeutic threshold. This does not usually cause an immediate emergency reaction like an allergic response. Instead, it leads to a state of relative hypothyroidism. Over time, this can manifest as fatigue, weight gain, sensitivity to cold, constipation, dry skin, and hair loss. In more severe cases, particularly for individuals with pre-existing heart conditions or those who are elderly, the lack of adequate thyroid hormone can lead to serious cardiovascular complications, including an increased risk of high cholesterol and even heart failure.
Furthermore, levothyroxine has a very narrow therapeutic index, meaning there is little room between the dose that works and the dose that causes issues. However, in this specific case, the danger lies in the opposite direction: under-treatment. Because the drug is subpotent, your body effectively goes into withdrawal from its required hormone levels. For patients who are stable on their current dosage, this sudden drop can disrupt their metabolic balance significantly. It is important to understand that because the potency issue is internal to the tablet’s chemical composition, it cannot be detected by looking at the pill’s color, shape, or imprint. The only way to know if a batch is affected is through the lot numbers and expiration dates provided in this notice.
This type of hazard is particularly concerning for chronic medication users because the effects accumulate. You might not feel "sick" in the acute sense, but your body’s baseline function is being compromised. This is why the FDA classifies this as a Class II recall—a situation where use or exposure to the product may cause temporary health problems or pose a slight threat of a serious nature. The risk is not that the drug will hurt you directly through toxicity, but that it will fail to protect you from the progression of your underlying condition.
Who is most at risk
The primary group affected by this recall consists of individuals who have been prescribed Levothyroxine Sodium Tablets, USP, 25 mcg (0.025 mg) in 1000-count bottles manufactured by Accord Healthcare, Inc. This specific dosage is often part of a long-term maintenance regimen for adults managing hypothyroidism, a condition where the thyroid gland does not produce enough thyroid hormone. Because the affected product is classified as a Class II recall, indicating that use or exposure to the product might cause temporary or medically reversible health problems, the risk is significant but generally manageable if addressed promptly. The individuals most directly at risk are those who possess unopened bottles with lot numbers D2401927, D2401833, D2402551, D2402552, D2500220, or D2500223. However, the vulnerability extends beyond just ownership to physiological dependence.
The people most vulnerable to the consequences of a subpotent drug are those with conditions that require precise hormonal balance. Levothyroxine is not a typical pain reliever or antibiotic; it is a hormone replacement. For patients with hypothyroidism, even small deviations in dosage can lead to noticeable changes in how their body functions. While this specific batch is subpotent (meaning it contains less active ingredient than labeled), the risk is particularly acute for elderly patients, who may already have compromised cardiovascular health or reduced metabolic clearance. In older adults, under-dosing can exacerbate fatigue, depression, and cognitive slowing, but more critically, it can place additional strain on the heart over time as the body struggles to maintain adequate metabolic rates.
Another highly vulnerable group includes patients with severe or long-standing hypothyroidism who have little physiological reserve. For these individuals, a sudden drop in effective hormone levels can trigger a rapid return of symptoms such as extreme lethargy, cold intolerance, weight gain, and dry skin. While the FDA has not reported any injuries or illnesses from this specific recall yet, the nature of thyroid medication means that "waiting it out" is not a safe strategy for everyone. Pregnant women are also in a high-risk category because thyroid hormone levels are critical for fetal brain development; however, since this recall involves a 25 mcg dose, which is relatively low, the absolute risk to a fetus depends heavily on whether this is the patient’s total daily requirement or just one part of a multi-tablet regimen. Generally, any disruption in thyroid hormone stability can lead to increased heart rate, anxiety, or palpitations as the body attempts to compensate for the lack of metabolic support.
It is also important to note that patients who rely on this specific 1000-count bottle format may be at higher risk of prolonged exposure if they do not check their lot numbers. Large bulk bottles are often used by individuals seeking cost savings or convenience, meaning they might continue taking the subpotent medication for weeks before realizing there is an issue. This extended period of under-medication can lead to a gradual decline in quality of life, including muscle weakness, joint pain, and elevated cholesterol levels, which are common markers of untreated hypothyroidism. Therefore, the risk is not just about immediate harm, but about the silent erosion of health stability for those who depend on this medication for daily function.
How to tell if you have the recalled item
Identifying whether a medication is part of this specific recall requires a careful, step-by-step examination of your prescription bottle. Because the recall involves Levothyroxine Sodium Tablets manufactured by Intas Pharmaceuticals Limited for Accord Healthcare, Inc., you cannot rely on general brand names or packaging styles alone. You must verify four critical pieces of information printed directly on the label: the National Drug Code (NDC), the specific lot numbers, and the expiration date. If even one of these details does not match the recall data exactly, your bottle is likely safe from this particular issue.
First, locate the NDC number on your bottle’s label. For this recall, the only affected product carries the unique identifier NDC 16729-447-17. This code is typically found near the bottom or side of the label. If your bottle has a different NDC number, it is not part of this specific recall action, even if it contains Levothyroxine Sodium. Next, you must check the lot number and expiration date together, as the recall applies to specific batches with distinct expiry windows. The affected lot numbers are D2401927, D2401833, D2402551, D2402552, D2500220, and D2500223. Each of these lots has a corresponding expiration date that you must verify:
- Lots D2401927 and D2401833 expire on August 31, 2026.
- Lots D2402551 and D2402552 expire on November 30, 2026.
- Lot D2500220 expires on December 31, 2026.
- Lot D2500223 expires on January 31, 2027.
It is crucial to understand that this recall applies specifically to the 25 mcg (0.025 mg) strength of Levothyroxine Sodium Tablets. The product is distributed in 1000-count bottles and is labeled as Rx Only, meaning it was dispensed through pharmacies rather than sold over-the-counter. The label should also indicate that the product was manufactured for Accord Healthcare, Inc., located in Raleigh, NC, and manufactured by Intas Pharmaceuticals Limited in Selaqui, Dehradun, India. If your bottle is a different strength, a different count size, or lacks these specific manufacturer details, it is not included in this recall.
If you are unsure where to find this information, look at the vertical side of the prescription label or the back panel of the bottle. Pharmacists often print the lot number and expiration date in a small box or near the barcode. If the label is worn off or illegible, contact the pharmacy where you filled your prescription. They can pull up your dispensing record, which will show the exact lot number and NDC for the medication provided to you. Do not guess; verify these numbers against the list above. If your bottle matches the NDC 16729-447-17 and any of the listed lot numbers, do not stop taking your medication abruptly. Instead, follow the steps outlined in the next section to arrange for a replacement or refund through your healthcare provider.
What to do — step by step
When you receive news of a drug recall, especially one involving a critical medication like levothyroxine, it is natural to feel a mix of confusion and concern. However, the most important thing right now is to act calmly and methodically. Because the FDA recall notice for Accord Healthcare’s Levothyroxine Sodium Tablets does not explicitly state a specific remedy—such as a direct return address, a prepaid shipping label, or a specific refund process—you must take proactive steps to ensure your safety and resolve the issue correctly. Do not assume that the medication is safe to finish simply because you have already started taking it, and do not dispose of it in a way that could harm others or the environment. Instead, follow these concrete steps to navigate this situation safely. First, immediately stop taking the affected tablets. Levothyroxine is used to treat hypothyroidism, a condition where your thyroid gland does not produce enough hormones. The recalled lots are identified as "subpotent," meaning they contain less of the active ingredient than the label claims. If you continue taking subpotent doses, your body may not receive the hormone levels it needs to regulate metabolism, heart rate, and energy. This can lead to a worsening of hypothyroidism symptoms, such as extreme fatigue, weight gain, cold sensitivity, and depression. By stopping use right away, you prevent further exposure to an unreliable dose. However, do not stop abruptly without a plan in place, as sudden changes in hormone levels can be jarring for your body. Second, contact your prescribing healthcare provider or pharmacist today. This is the most critical step because they hold the key to your continued care. Call their office and inform them that you have been prescribed Accord Healthcare’s Levothyroxine Sodium Tablets, 25 mcg, specifically from the recalled lots (D2401927, D2401833, D2402551, D2402552, D2500220, or D2500223). Your doctor needs to know this immediately so they can assess your current thyroid levels and determine if you need a blood test (TSH level) sooner than scheduled. They will also help you transition to a different manufacturer’s version of the medication. It is vital that you do not switch brands or manufacturers without medical supervision, as even small differences in bioavailability between manufacturers can affect how your body absorbs the drug. Your doctor may call in a new prescription to a different pharmacy for you. Third, secure an alternative source of your medication. Since the recall is nationwide, you may need to visit multiple pharmacies to find stock from a different manufacturer. Ask your pharmacist if they have Levothyroxine from another maker, such as Synthroid, Tirosint, or Unithroid, and whether your insurance will cover the switch without penalty. If your current pharmacy cannot provide an alternative immediately, ask them to check with nearby locations or order it for you. Do not attempt to refill your old prescription at a different counter; the system may still flag it as the recalled product. Fourth, handle the recalled bottles responsibly. Since the recall notice does not provide a specific return address or prepaid shipping label, do not send the medication back to Accord Healthcare or Intas Pharmaceuticals unless you have received explicit instructions via official FDA channels or your pharmacy. Instead, ask your pharmacist or local health department about proper disposal methods. Many communities have drug take-back programs where you can drop off unused medications securely. If no take-back program is available, follow FDA guidelines for home disposal: mix the tablets with an unappealing substance like dirt, cat litter, or used coffee grounds in a sealed plastic bag before throwing them in the trash to prevent others from retrieving them. Do not flush them down the toilet unless specifically instructed to do so. Finally, monitor your body and stay in close contact with your doctor. As you transition to the new medication, pay attention to how you feel. It may take several weeks for your thyroid levels to stabilize on the new dose. Keep a log of any symptoms, such as changes in energy, heart rate, or temperature sensitivity, and report them to your healthcare provider. This recall highlights the importance of knowing your lot numbers and maintaining open lines of communication with your medical team to ensure uninterrupted care.Your refund, repair, or replacement options
When you encounter a recall notice for a prescription medication like the Levothyroxine Sodium Tablets issued by Accord Healthcare, Inc., your immediate instinct might be to rush to the pharmacy or call customer service. However, it is crucial to pause and understand that the specific remedy for this particular recall has not been explicitly stated in the official FDA report. This absence of a predefined replacement or refund protocol is actually quite common in pharmaceutical Class II recalls, especially those involving subpotent drugs where the primary concern is patient safety rather than monetary compensation. Because the hazard here is that the drug may not contain the full strength of the active ingredient, the focus shifts entirely from "getting your money back" to "stopping exposure to potentially ineffective treatment." Therefore, you should not expect a standard retail return process with a receipt scan and immediate cash refund.
The most important first step is to contact the healthcare professional who prescribed this medication for you. Your doctor or pharmacist is your primary resource because they can verify the specific lot numbers against current FDA databases and, more importantly, prescribe a new batch of Levothyroxine from a different manufacturer or lot if necessary. Since this product was distributed nationwide in 1000-count bottles, it is likely that you are either a long-term patient with a large stockpile or potentially part of an institutional distribution network. If you are an individual consumer holding one of these bottles, do not attempt to return the product to a retail store on your own without professional guidance. Retailers often have strict protocols for returning prescription drugs due to safety regulations, and they may require a recall authorization number that you might not have yet.
If you are looking for direct contact information for Accord Healthcare, Inc., the recall facts do not provide a specific phone number or website for consumer inquiries in this instance. This does not mean help is unavailable; rather, it means the FDA relies on the healthcare provider network to manage the distribution of remedies. You should check the packaging of your bottle again for any lot-specific instructions that might have been added after the initial recall date of August 6, 2026. If you cannot find any contact details on the label, reach out to Intas Pharmaceuticals Limited, the manufacturer listed on the bottle, though be aware that international manufacturers often route consumer inquiries through their U.S.-based marketing partners like Accord Healthcare.
In terms of financial restitution, because the remedy is not stated, any refund or compensation would likely need to be negotiated directly with your pharmacy or insurance provider. Many pharmacies will voluntarily replace recalled medications to maintain customer trust and ensure continuity of care, even if the official government notice does not mandate it. However, you should not rely on this as a guaranteed right without first confirming with your pharmacist. The key takeaway is that your health comes before the cost of the medication. If you are using a subpotent thyroid medication, the risk of untreated hypothyroidism far outweighs any inconvenience in obtaining a replacement. Prioritize getting a new prescription filled from a safe source immediately, and let the financial aspects be handled by your healthcare provider or pharmacy’s internal policies.
What can happen if you ignore it
When a medication like levothyroxine is recalled for being subpotent, the immediate risk isn't a sudden toxic reaction or an allergic response. Instead, the danger lies in what happens when your body doesn’t get the consistent, precise dose it has come to rely on. Levothyroxine is not a typical pain reliever or allergy medication that you might miss occasionally without major consequence. It is a hormone replacement therapy, and for many people, it is the only thing keeping their metabolism, heart rate, and energy levels stable. When the drug is subpotent, meaning it contains less of the active ingredient than labeled, your body effectively goes into a state of gradual, untreated hypothyroidism.
The consequences of ignoring this recall can be subtle at first, which is precisely why it is so dangerous. You might not feel "sick" in the traditional sense right away. Instead, you may notice a creeping fatigue that coffee doesn’t fix, a brain fog that makes concentrating at work difficult, or a cold sensitivity that seems to have appeared out of nowhere. These symptoms are classic signs that your thyroid hormone levels are dropping below the therapeutic range. Because these changes happen slowly, many patients assume they are just getting older, stressed, or busy, rather than realizing their medication is no longer doing its job. This delay in recognition allows the underlying condition to worsen without medical intervention.
If you continue taking subpotent levothyroxine for an extended period, the effects can become more serious and systemic. Your heart may begin to beat slower than normal (bradycardia), which can reduce blood flow to vital organs. Cholesterol levels can rise significantly, increasing long-term cardiovascular risks even if you feel fine in the moment. In more severe cases, untreated hypothyroidism can lead to fluid retention, swelling in the face and extremities, and significant weight gain that is difficult to reverse through diet or exercise alone. For individuals with pre-existing heart conditions, this added strain on the cardiovascular system can be particularly hazardous.
For certain vulnerable groups, the stakes are even higher. Pregnant women relying on levothyroxine face risks to fetal brain development if hormone levels drop too low. Patients who have had thyroid cancer removed depend on precise suppression of their thyroid-stimulating hormone (TSH) to prevent recurrence; subpotent doses may inadvertently allow TSH to rise, potentially stimulating any remaining microscopic disease cells. Furthermore, because levothyroxine has a very narrow therapeutic index, small changes in dosage can lead to large swings in how you feel and function. Ignoring the recall means leaving your health to chance during a time when you need precision most.
The good news is that these outcomes are largely preventable. The remedy for this specific issue is straightforward: stop taking the recalled bottles and switch to a verified, non-recalled source of levothyroxine under your doctor’s guidance. Once you resume receiving the correct dose, your body typically responds quickly, with energy levels and metabolic markers improving over days to weeks. Do not wait for symptoms to become severe before acting. Reaching out to your pharmacist or healthcare provider today is the most effective way to protect your long-term health.
Staying safe: broader tips
Managing prescription medications requires a proactive approach to safety that extends far beyond responding to individual recalls. While specific product issues are rare and heavily regulated, maintaining the integrity of your medication supply chain is a shared responsibility between manufacturers, regulators, and consumers. One of the most effective ways to protect yourself is to stay informed about how the FDA monitors drug quality. The agency conducts rigorous testing for potency, purity, and manufacturing consistency, but they rely on public reporting to identify anomalies quickly. You can subscribe to email alerts from the FDA’s Office of Surveillance and Compliance or check their website regularly. This habit ensures you are not caught off guard by updates regarding your specific prescriptions, allowing you to act calmly and efficiently if a warning arises.
Another critical aspect of medication safety is proper storage. Environmental factors such as humidity, heat, and light can degrade active ingredients over time, potentially leading to subpotent drugs that do not provide the therapeutic effect needed. For thyroid medications like levothyroxine, which are particularly sensitive to environmental conditions, storing them in a cool, dry place away from direct sunlight is essential. Avoid keeping them in bathrooms where steam and temperature fluctuations are common. Always keep medications in their original containers with the labels intact, as these provide vital information about expiration dates and lot numbers. If you notice any changes in color, texture, or smell, do not take the medication; contact your pharmacist immediately for guidance.
Building a strong relationship with your healthcare provider and pharmacist is also key to long-term safety. They can help you verify that your prescriptions are genuine and manufactured by reputable facilities. When filling a new prescription, take a moment to inspect the bottle for any signs of tampering or irregularities. Report any adverse reactions or unusual side effects to your doctor and consider filing a MedWatch report with the FDA. This feedback loop helps regulatory bodies detect patterns that might indicate broader manufacturing issues before they affect larger populations. By staying engaged in your health care team, you create a robust safety net around your treatment plan.
Finally, consider organizing your medications regularly. Set aside time each month to check expiration dates and dispose of any outdated drugs safely. Many pharmacies and local law enforcement agencies offer take-back programs for unused or expired medications, which prevents them from entering the waste stream where they could be misused or cause environmental harm. This routine not only keeps your medicine cabinet safe but also ensures you are always using products that are within their validated shelf life. Being vigilant about these general practices empowers you to manage your health with confidence and reduces the risk of unexpected complications from medication issues.